Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB13915	Axicabtagene ciloleucel	1	Recruiting	1
DB02379	Beta-D-Glucose	1	Withdrawn	1
DB00262	Carmustine	1	Withdrawn	1
DB00531	Cyclophosphamide	1	Not Yet Recruiting	1
DB00987	Cytarabine	1	Withdrawn	1
DB16395	Efineptakin alfa	1	Recruiting	1
DB00773	Etoposide	1	Withdrawn	1
DB01073	Fludarabine	1	Not Yet Recruiting	1
DB16582	Lisocabtagene maraleucel	1	Recruiting	1
DB16222	Loncastuximab tesirine	1	Withdrawn	1
DB00888	Mechlorethamine	1	Withdrawn	1
DB13881	Tisagenlecleucel	1	Recruiting	1
DB17573	Evorpacept	1 / 2	Recruiting	1
DB00480	Lenalidomide	1 / 2	Recruiting	1
DB00073	Rituximab	1 / 2	Recruiting	1
DB00026	Anakinra	2	Active Not Recruiting	1
DB00026	Anakinra	2	Recruiting	1
DB13915	Axicabtagene ciloleucel	2	Active Not Recruiting	1
DB13915	Axicabtagene ciloleucel	2	Recruiting	1
DB02379	Beta-D-Glucose	2	Recruiting	1
DB00958	Carboplatin	2	Recruiting	1
DB00531	Cyclophosphamide	2	Active Not Recruiting	1
DB00531	Cyclophosphamide	2	Recruiting	2
DB00773	Etoposide	2	Recruiting	1
DB01073	Fludarabine	2	Active Not Recruiting	1
DB01073	Fludarabine	2	Recruiting	1
DB01181	Ifosfamide	2	Recruiting	1
DB00480	Lenalidomide	2	Recruiting	1
DB09037	Pembrolizumab	2	Recruiting	1
DB15044	Tafasitamab	2	Recruiting	1